THORACOFLO Trademark

Trademark Overview


On Wednesday, July 3, 2019, a trademark application was filed for THORACOFLO with the United States Patent and Trademark Office. The USPTO has given the THORACOFLO trademark a serial number of 79269640. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Vascutek Limited. The THORACOFLO trademark is filed in the Medical Instrument Products category with the following description:

Surgical, medical, dental and veterinary apparatus and instruments; artificial vascular grafts, artificial stent grafts, artificial thoracic, thoracoabdominal and abdominal stent grafts, surgical hybrid stent graft for treatment of thoracoabdominal aortic aneurysms, stents, patches for repair and reconstruction of internal tissue, and vascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices namely, artificial endovascular stent grafts; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials namely, artificial endovascular grafts, artificial endovascular grafts; medical systems, namely, systems for use in artificial organ support; medical devices for measuring blood sugar for ...
thoracoflo

General Information


Serial Number79269640
Word MarkTHORACOFLO
Filing DateWednesday, July 3, 2019
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6160714
Registration DateTuesday, September 29, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements


Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments; artificial vascular grafts, artificial stent grafts, artificial thoracic, thoracoabdominal and abdominal stent grafts, surgical hybrid stent graft for treatment of thoracoabdominal aortic aneurysms, stents, patches for repair and reconstruction of internal tissue, and vascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices namely, artificial endovascular stent grafts; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials namely, artificial endovascular grafts, artificial endovascular grafts; medical systems, namely, systems for use in artificial organ support; medical devices for measuring blood sugar for medical purposes; surgical systems namely stent delivery systems; surgical devices; devices comprising an artificial vascular graft and a stent; devices comprising an artificial vascular graft, a stent and a delivery system; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in thoracoabdominal procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in aortic arch procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in endovascular procedures; thoracic stents; artificial thoracic stent grafts; thoracoabdominal stents; artificial thoracoabdominal stent grafts; artificial stent grafts; artificial stent graft systems; artificial stent graft devices; artificial stent graft systems and surgical devices comprising more than one component; artificial stent graft systems and surgical devices comprising components of more than one stent graft; artificial stent graft systems and surgical devices comprising components of more than one type of stent graft; devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial thoracic stent graft systems; artificial thoracic stent graft devices; artificial thoracoabdominal stent graft systems; artificial thoracoabdominal stent graft devices; delivery systems for artificial stents and grafts; delivery systems for artificial stent graft systems and artificial stent graft devices; medical systems, namely, minimally invasive devices for aneurysm repair; medical devices, namely, minimally invasive devices for aneurysm repair; medical systems, namely, minimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; medical devices, namely, minimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; cardiac valves for surgical prostheses; cardiac valve replacement systems namely, artificial cardiac valves; artificial heart valves; artificial heart valve conduits; artificial cardiac patches; artificial vascular patches; parts and fittings for all of the aforementioned goods

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 18, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVascutek Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameVascutek Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameVascutek Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, February 13, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 22, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 22, 2021FINAL DISPOSITION PROCESSED
Tuesday, December 29, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 14, 2019REFUSAL PROCESSED BY IB
Friday, November 22, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 22, 2019REFUSAL PROCESSED BY MPU
Friday, November 1, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 31, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 22, 2019APPLICATION FILING RECEIPT MAILED
Friday, October 18, 2019ASSIGNED TO EXAMINER
Friday, October 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 17, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB